MKS Instruments Declares Quarterly Cash Dividend

ANDOVER, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on Read more

Thermo Fisher Scientific Publishes 2020 Corporate Social Responsibility Report

WALTHAM, Mass., Oct. 26, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published its 2020 Corporate Social Responsibility (CSR) report, reflecting its commitment to society, stakeholders and environmental, social and governance (ESG) efforts. The report provides detailed insight into the company’s approach to CSR, outlines future priorities and... Read more

PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams

Secure, SaaS informatics platform drives streamlined workflows and accelerated decision-making for pharmaceutical and industrial customers   WALTHAM, Mass. – October 25, 2021– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its Signals Research™ Suite , a full cloud based solution, deployed on Amazon Web Services. The... Read more

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. This is the first time that research scientists can conduct oncology research with Foundation Medicine’s comprehensive genomic profiling in their own laboratories to gain... Read more

Imaging the Cytoskeleton to Understand Schizophrenia

Upper left: Prof. Takeo Yoshikawa, RIKEN Center for Brain Science; Upper right: Prof. Nobutaka Hirokawa, University of Tokyo; Lower, members of Dr. Hirokawa’s lab – from left to right – Dr. Momo Morikawa, Shogo Yoshihara and Dr. Yosuke Tanaka. Schizophrenia is a mental disorder in which patients often suffer hallucinations, delusions and disordered thinking that... Read more

BD Names Dr. Carrie Byington To Board Of Directors

FRANKLIN LAKES, N.J., Oct. 22, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company’s board of directors, bringing the total number of directors to 13. Byington, 58, is executive vice president and head of University of California Health (UCH), where she... Read more

FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD)

Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with nAMD maintain their vision with as few as... Read more

GE Healthcare Advances Precision Radiation Therapy Solutions with New Products, Partners and Solutions at #ASTRO21

Chicago – October 22, 2021: At this year’s ASTRO 2021 event, GE Healthcare will showcase over 15 innovative multi-modality radiation therapy solutions, offering medical practitioners imaging tools and support they need to improve patient-centered care and advance the practice of precision medicine. “GE Healthcare aims to drive improved patient outcomes through cutting-edge multi-modality radiation therapy... Read more